Matches in Ghent University Academic Bibliography for { <https://biblio.ugent.be/publication/01GJCFVV5RAW873HCCS0YXSXRM> ?p ?o. }
Showing items 1 to 26 of
26
with 100 items per page.
- 01GJCFVV5RAW873HCCS0YXSXRM classification A1.
- 01GJCFVV5RAW873HCCS0YXSXRM date "2022".
- 01GJCFVV5RAW873HCCS0YXSXRM language "eng".
- 01GJCFVV5RAW873HCCS0YXSXRM type journalArticle.
- 01GJCFVV5RAW873HCCS0YXSXRM hasPart 01GJCFY76GJB6TAMEJB2RV2X7C.pdf.
- 01GJCFVV5RAW873HCCS0YXSXRM subject "Medicine and Health Sciences".
- 01GJCFVV5RAW873HCCS0YXSXRM doi "10.1016/j.ejon.2022.102218".
- 01GJCFVV5RAW873HCCS0YXSXRM issn "1462-3889".
- 01GJCFVV5RAW873HCCS0YXSXRM issn "1532-2122".
- 01GJCFVV5RAW873HCCS0YXSXRM volume "61".
- 01GJCFVV5RAW873HCCS0YXSXRM abstract "Purpose: To investigate factors affecting the co-creation and implementation of care pathways for patients treated with oral anticancer drugs. Methods: An explorative qualitative process evaluation was performed at four Belgian hospitals, co-creating and implementing a care pathway for patients on oral anticancer drugs. Semistructured interviews and focus groups were performed by a) local coordinators leading an interprofessional project team during the co-creation and implementation stage, b) external implementation coaches, and c) teams of healthcare professionals with a role in the care pathway. In total, 47 stakeholders were interviewed. Interviews were audio-taped, transcribed verbatim, and analyzed thematically. Results: We found four factors affecting co-creation and implementation of care pathways for patients on oral anticancer drugs. Developing an adequate supporting context using motivated interprofessional project teams of clinical and management staff led by competent coordinators is one important facilitator. Leadership of local coordinators and oncologists is crucial for progressing the co-creation. Other factors included the complexity of the oral anticancer drug intervention, the interprofessional character of the care pathway, and involving primary care. External coaching during co-creation proved an important facilitator. Conclusions: Prior investigation of willingness and motivation to change in clinical and management staff, competent coordinators, and leadership of oncologists are needed. In addition, external support determines the success of co-creating and implementing care pathways for patients on oral anticancer drugs.".
- 01GJCFVV5RAW873HCCS0YXSXRM author 19ED1C08-1C4F-11E5-BBB2-CEE7B4D1D7B1.
- 01GJCFVV5RAW873HCCS0YXSXRM author 8d40c178-4897-11eb-bce0-d97a09885304.
- 01GJCFVV5RAW873HCCS0YXSXRM author AEE5751E-C5C8-11E8-8987-A2685607D3EF.
- 01GJCFVV5RAW873HCCS0YXSXRM author F702A1AC-F0ED-11E1-A9DE-61C894A0A6B4.
- 01GJCFVV5RAW873HCCS0YXSXRM author FF3CA47A-760F-11E6-9590-2904B5D1D7B1.
- 01GJCFVV5RAW873HCCS0YXSXRM author urn:uuid:6cb84494-24c7-49c0-a73d-6c8eb84dd376.
- 01GJCFVV5RAW873HCCS0YXSXRM dateCreated "2022-11-21T07:01:28Z".
- 01GJCFVV5RAW873HCCS0YXSXRM dateModified "2024-11-28T00:16:49Z".
- 01GJCFVV5RAW873HCCS0YXSXRM name "A qualitative evaluation of the process of creating and implementing an interprofessional care pathway for patients treated with oral anticancer drugs".
- 01GJCFVV5RAW873HCCS0YXSXRM pagination urn:uuid:be696522-a2b7-4582-8466-2a300fe0435f.
- 01GJCFVV5RAW873HCCS0YXSXRM publisher urn:uuid:bd82a7f0-285e-4346-8f46-28b435440d4e.
- 01GJCFVV5RAW873HCCS0YXSXRM sameAs LU-01GJCFVV5RAW873HCCS0YXSXRM.
- 01GJCFVV5RAW873HCCS0YXSXRM sourceOrganization urn:uuid:23c54bc7-725b-4302-bd8a-29f2290d0134.
- 01GJCFVV5RAW873HCCS0YXSXRM sourceOrganization urn:uuid:a9f70b96-1ea8-46bb-9878-e81a55e908ce.
- 01GJCFVV5RAW873HCCS0YXSXRM type A1.